About Namrata Sen Chanda

Namrata is an accomplished financial journalist, with nearly a decade of experience. She specializes in interpreting news releases and framing investment strategies, and has worked with some of the leading companies in real estate, banking, insurance, mutual funds, financial research, fintech, and investment education. After majoring in finance at college, she became a research analyst, tracking economic indicators and analyzing major global economic developments. She then went on to become a contributing author for the Market Realist, focusing on the technology sector. Namrata has a keen interest in fundamental analysis and is passionate about educating investors about the stock market.


Recent Articles By Namrata Sen Chanda

: MSFT |  News, Ratings, and Charts

3 "Buy Rated" Stocks on the Robinhood 100 That Pay Dividends

Among the stocks on the Robinhood 100 List, ones with solid growth potential and a stable dividend-paying history are ideal picks amid the prevailing market uncertainty. Microsoft (MSFT), Johnson & Johnson (JNJ), and Walmart (WMT) are three such stocks that could cushion your portfolio now and offer solid long-term returns. 
: MSFT |  News, Ratings, and Charts

3 Top Tech Stocks to Buy for a Second Wave of the Coronavirus

As the second wave of COVID-19 is beginning to appear in parts of the world, businesses and individuals will become increasingly reliant on technology. Cloud operators like Microsoft (MSFT), Adobe (ADBE), and Salesforce.com (CRM) are well-positioned to meet the increase in demand.
: EXAS |  News, Ratings, and Charts

4 Biotech Stocks Robinhood Investors Love

The Robinhood app popularity among younger and more-aggressive investors. So, it’s natural they would be interested in biotech given the huge upside of many stocks in the sector. Here are some of the biotech stocks that Robinhood investors love because of their enormous  potential: Exact Sciences (EXAS), Moderna (MRNA), Medtronic (MDT), and Amgen (AMGN).
: SQ |  News, Ratings, and Charts

4 Stocks That Could Skyrocket During the Next Crypto Boom

Cryptocurrency investors made huge profits when bitcoin went parabolic a couple of years ago. Square (SQ), PayPal (PYPL), Nvidia (NVDA), and CME Group (CME) are the prominent public companies with crypto exposure.
: APAM |  News, Ratings, and Charts

4 Momentum Stocks With High Dividend Yields

The market is now fretting with uncertainty over the Presidential election, increasing COVID-19 cases, and concerns over fiscal stimulus. It’s time to focus on stocks that have been witnessing strong momentum and offer a steady income through dividend payments. This combination could help your portfolio easily survive market volatility. In this light, Artisan Partners Asset Management (APAM), Clearway Energy (CWEN), Rent-A-Center (RCII), and Pitney Bowes (PBI) are worth a watch.
: AAPL |  News, Ratings, and Charts

4 Stocks to AVOID if the Democrats Win the White House and Senate

If the Democrats win the Presidential election in November and win a majority in the Senate, it could spell trouble for the four technology giants. Tougher antitrust laws, the increasing risk of a breakup, and a restriction on acquisitions could completely alter the business for Apple (AAPL), Facebook (FB), Amazon (AMZN), and Alphabet (GOOGL). 
: PANW |  News, Ratings, and Charts

4 Cybersecurity Stocks to Protect Your Portfolio From a Second Wave of COVID-19

As dependence on technology has been increasing due to the coronavirus, data and network security has become more critical than ever. As a result, the demand for cybersecurity is rapidly increasing and companies are ramping up their IT budgets. Palo Alto Networks (PANW), Zscaler (ZS), Cloudflare (NET), and Check Point Software Technologies (CHKP) are riding high and are worthwhile investments to protect your portfolio from a possible second wave of COVID-19.
: PCTY |  News, Ratings, and Charts

4 ‘Under the Radar’ Software Stocks that are "Strong Buys"

Paylocity Holding (PCTY), Five9  (FIVN), Manhattan Associates (MANH), and SailPoint Technologies (SAIL) are delivering disruptive technological solutions. Cloud computing and AI are two of the biggest growth-areas, so investors need to pay attention to these underfollowed stocks. 
: INFY |  News, Ratings, and Charts

3 Top Tech Stocks Under $20

Tech is the big post-pandemic winner. These companies were already growing faster than other companies before the coronavirus, but the pandemic has led to an acceleration in sales and market share. Additionally, low rates and slower economic growth increase the premium for “secular growth” stocks. Many tech stocks are now quite expensive, but these tech stocks remain attractively priced: Infosys (INFY), SunPower (SPWR), and Avaya Holdings (AVYA) could be the best approach.  
: ABT |  News, Ratings, and Charts

3 Pharmaceutical Stocks to Buy & Hold for the Rest of the Year

As COVID cases exceed 7.5 million in the US and most states seeing an increase, fears of the second wave are rising. The demand for treatment or a vaccine is higher than ever. That fear and an aging population have pharmaceutical stocks such as Abbott Laboratories (ABT), Novo Nordisk (NVO), and Zoetis Inc. (ZTS) poised for long-term gains.
Page generated in 1.662 seconds.